Quiz. b. 4 High grade c. 9 Unknown

Similar documents
Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

11/21/13 CEA: 1.7 WNL

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Histology Coding ANSWERS

A patient with recurrent bladder cancer presents with the following history:

Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast

Case Scenario 1. Pathology: Specimen type: Incisional biopsy of the glottis Histology: Moderately differentiated squamous cell carcinoma

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Breast Cancer. Saima Saeed MD

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

Prostate Overview Quiz

Q&A. Fabulous Prizes. Collecting Cancer Data:Coding Pitfalls 9/5/13. NAACCR Webinar Series Coding Pitfalls

SEER Summary Stage Still Here!

Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:

Coding Pitfalls 9/1/2011. Coding Pitfalls Questions. Fabulous Prizes!!! September 1, NAACCR Webinar Series 1

Collecting Cancer Data: Breast. Prizes! Collecting Cancer Data: Breast 8/4/ NAACCR Webinar Series 1. NAACCR Webinar Series

Interactive Discussion of Part I CS Coding Instructions: Working the Cases

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #

Breast Cancer. Dr. Andres Wiernik 2017

UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ 2 Primary Site (291) = C711 Date of Diagnosis (283) =

Basement membrane in lobule.

Anaplastic A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells.

NAACCR Webinar Series /7/17

BREAST SURGERY PROGRESS TEST Name:

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

It is a malignancy originating from breast tissue

List of Available TMAs in the PRN

A916: rectum: adenocarcinoma

Breast Cancer Diagnosis, Treatment and Follow-up

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Thyroid and Adrenal Gland

Breast Cancer Basics. Clinical Oncology for Public Health Professionals. Ben Ho Park, MD, PhD

Colon and Rectum 5/1/14

Coding Pitfalls 9/11/14

A superficial radiotherapy B single pass curettage C excision with 2 mm margins D excision with 5 mm margins E Mohs micrographic surgery.

Overview. Collecting Cancer Data: Colon 11/5/2009. Collecting Cancer Data: NAACCR Webinar Series 1. Agenda NAACCR WEBINAR SERIES

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

Radiology- Pathology Conference 4/29/2012. Lymph Nodes. John McGrath

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

What is endometrial cancer?

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Primary Care Approach to Genetic Cancer Syndromes

NAACCR Webinar Series 1 Q&A. Fabulous Prizes. Collecting Cancer Data: Ovary 11/3/2011. Collecting Cancer Data: Ovary

Cancer Endorsement Maintenance 2011-Maintenance Measures

Bringing the Fight to Cancer Annual Report

One of the commonest gynecological cancers,especially in white Americans.

3. This data item records the grade of a solid primary tumor that had been resected following neoadjuvant therapy. a. Grade Post Therapy

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

Cancer Program Report 2014

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

A215- Urinary bladder cancer tissues

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Radiation Oncology MOC Study Guide

Bringing the Fight to Cancer Annual Report

Boot Camp Case Scenarios

Cancer Research Group Version Date: November 5, 2015 NCI Update Date: January 15, Schema. L O Step 1 1,2

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates

Case Scenario 1. History

FINE NEEDLE ASPIRATION OF ENLARGED LYMPH NODE: Metastatic squamous cell carcinoma

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

BLADDER CANCER: PATIENT INFORMATION

Breast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment?

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

Completing the Puzzle AJCC TNM Staging Breast. Nicole Catlett, CTR 2017 Kentucky Cancer Registry Fall Conference, September 21 & 22, 2017

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018

Index. Note: Page numbers of article titles are in boldface type.

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer

Urinary Bladder, Ureter, and Renal Pelvis

Boot Camp 2014 Quiz. D: surgical puncture

FINALIZED SEER SINQ QUESTIONS January June, 2016

Definition of Synoptic Reporting

Collaborative Staging Manual and Coding Instructions Part II: Primary Site Schema

FINALIZED SEER SINQ S MAY 2012

Multiple Primary Quiz

Coding Pitfalls 9/11/14

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

NATIONAL QUALITY FORUM

SEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING

Interactive Staging Bee

Transcription:

Quiz 1. 10/11/12 CT scan abdomen/pelvis: Metastatic liver disease with probable primary colon malignancy. 10/17/12 Colonoscopy with polypectomy: Adenocarcinoma of sigmoid colon measuring at least 6 mm in diameter arising within a tubulovillous adenoma with high grade dysplasia. Tumor invades submucosa and extends to cauterized margin. 10/29/12 Patient begins chemotherapy. 2/5/13 Sigmoid colectomy: 2 mm focus of well differentiated intramucosal adenocarcinoma. What is the code for grade? b. 4 High grade c. 9 Unknown 2. Final pathologic diagnosis: Well differentiated noninvasive adenocarcinoma in a sigmoid colon polyp. What is the code for grade? b. 9 Unknown 3. Final pathologic diagnosis: Moderately differentiated transitional call carcinoma of the bladder with a focus of poorly differentiated carcinoma. What is the code for grade? a. 2 Moderately differentiated b. 3 Poorly differentiated c. 9 Unknown 4. Final pathologic diagnosis: Endometrial adenocarcinoma confined to the endometrium with a focus of well differentiated in situ adenocarcinoma. What is the code for grade? b. 9 Unknown 5. Total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH-BSO): 3 cm lesion of the endometrium, poorly differentiated papillary serous adenocarcinoma, invades inner half of the myometrium. What is the histology code? a. 8260/3 Papillary adenocarcinoma b. 8323/3 Mixed cell adenocarcinoma c. 8441/3 Serous adenocarcinoma d. 8460/3 Papillary serous adenocarcinoma

6. 12/4/12 Abdominal/pelvic CT scan: Sigmoid lesion, most likely malignant; pericolic lymphadenopathy; liver lesions, possibly metastastic. 12/11/12 Hemicolectomy, lymph node dissection, & wedge resection of liver: 4 cm sigmoid colon adenocarcinoma invaded pericolic fat; 2/20 pericolic nodes with metastasis; liver lesions benign. What is the code for surgical procedure/other site? a. 0 None b. 3 Non primary surgical procedure to distant lymph nodes c. 4 Non primary surgical procedure to other distant sites d. 5 Combination of 3 and 4 7. Final pathologic diagnosis: 1.5 cm lesion of right thyroid lobe with follicular carcinoma and papillary microcarcinoma. What is the histology code? a. 8260/3 Papillary adenocarcinoma b. 8330/3 Follicular adenocarcinoma c. 8340/3 Papillary carcinoma, follicular variant d. 8341/3 Papillary microcarcinoma 8. Biopsy proven squamous cell carcinoma of the oropharynx. CT scan of neck shows 3 cm oropharyngeal mass, 1.5 cm cervical lymph node, probably malignant, 7 cm submandibular nodal mass, probably malignant and probably made up of multiple nodes. What is the code for SSF1 (Size of Lymph Nodes)? a. 015 b. 030 c. 070 d. 999 Unknown 9. Patient had extensive urothelial bladder cancer 5 years ago and had radical cystectomy with Indiana pouch reconstruction. Indiana pouch was made from ascending colon. In January 2013 patient is diagnosed with adenocarcinoma of the Indiana pouch. What is the primary site? a. C18.2 Ascending colon b. C18.9 Colon NOS c. C67.9 Bladder NOS d. C80.9 Unknown primary site 10. 1/15/13 CT scan of chest: 3.5 cm soft tissue mass of chest wall 1/22/13 Resection of chest wall mass: Superficial invasive sarcoma, right chest wall. What is the code for CS TS/Ext Eval? a. 0 Non-invasive clinical evidence b. 3 Surgical resection

11. Which of the following is not a reportable case if they are a primary of the brain? a. Hemangioma, nos (9120/0) b. Cavernous hemangioma (9121/0) c. Venous hemangioma (9122/0) d. None of the histologies above are reportable for primaries of the brain 12. Based on the chart below indicate all of the histology combinations that are on the same branch. a. Astroblastoma (9430) and Astrocytoma (9400) b. Astrocytoma, NOS (9400) and Gemistocytic Astrocytoma (9411) c. Glioma, NOS (9380) and Mixed Glioma (9382) d. Astrocytoma, NOS (9400) and Glioblastoma, NOS (9440) 13. Histologic grade can be coded for which of the following site/histology combinations based on rules documented in the AJCC Manual? a. Small cell carcinoma of any site b. Large cell carcinoma of the lung c. Specific histologies for CNS listed in table 56.3 of the AJCC 7 th Ed. d. None of the above (table 56.3 can only be used to code WHO grade for CS SSF 1)

14. A tumor located at the 3:30 position of the right breast would be coded to a. Upper inner quadrant (C50.2) b. Lower inner quadrant (C50.3) c. Overlapping lesion of the breast (C50.8) d. Breast, NOS (C50.9) 15. Genomic testing like that done for the Oncotype DX can be used to predict (Circle all that apply.) a. If genes have mutated b. How likely (or unlikely) the breast cancer will recur c. How likely the chemotherapy will be of benefit d. How likely radiation therapy will be of benefit 16. A breast cancer patient had lumpectomy and axillary node dissection on 1/14/13. She returned on 1/21/13 for a simple mastectomy. No further surgical procedures were done. The surgery code for the 1/21/13 procedure would be a. 22-Lumpectomy b. 41-Simple mastectomy without removal of contralateral breast c. 51- Modified Radical Mastectomy without removal of uninvolved contralateral breast d. 80-Mastectomy, NOS 17. A breast cancer patient has opted to have breast conserving surgery (i.e. lumpectomy) as the only surgical treatment. We would expect the patient to go on and have. a. Tamoxifen b. Herceptin c. Adriamycin d. Radiation 18. For a patient under the age of 70 with AJCC Stage II infiltrating ductal carcinoma that is ER, PR, and HER2/neu negative, we would normally expect to see which type(s) of adjuvant therapy? (Circle all that apply.) a. Tamoxifen and/or an aromatase inhibitor b. Trastuzumab (Herceptin) c. Chemotherapy d. Active surveillance 19. For the purpose of applying the MP/H rules, the term "synchronous" means a. Two or more tumors diagnosed during the same procedure b. Two or more tumors diagnosed on the same day c. Two or more tumors diagnosed at the same time or less than or equal to 60 days apart d. Two or more tumors diagnosed more than 60 days apart

20. A patient is diagnosed with a papillary urothelial carcinoma of the bladder on 1/6/09. On 6/13/10 he is found to have a papillary urothelial carcinoma of the right renal pelvis. On 1/14/13 he is found to have an urothelial carcinoma of the ureter. On 7/14/13 he is found to have urothelial carcinoma of the right renal pelvis. According to rule M7 this patient has two primaries (Rule M7-Tumors diagnosed more than three (3) years apart are multiple primaries). What is the data of diagnosis for the second primary? a. 6/13/10 b. 1/14/13 c. 7/14/13 d. None of the above